Imunotherapy opportunities in ovarian cancer

Imunotherapy opportunities in ovarian cancer

In the last decade, accumulated evidence in favor of that ovarian cancer is an immunogenic tumor. Immunotherapy is aimed at stimulating the innate and adaptive immunity, may cause an effective response in patients with ovarian cancer. Various approaches immunotherapy include cytokinetherapy, use of...

Full description

Bibliographic Details
Main Authors:	I. Zh. Shubina, A. N. Gritsay, L. T. Mamedova, N. Yu. Sokolov, S. A. Kuznetsov, M. V. Kiselevskiy, N. I. Lazareva, V. V. Kuznetsov, K. S. Titov, A. P. Nikolayev
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Опухоли женской репродуктивной системы
Subjects:	ovarian cancer antitumor immunity immunotherapy
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/68

Similar Items

Characteristics of lymphocyte subpopulations in the peripheral blood and lymph nodes of patients with ovarian cancer
by: I. Zh. Shubina, et al.
Published: (2014-11-01)

Neoadjuvant chemotherapy for advanced ovarian cancer: literature data and in vitro studies
by: S. A. Kuznetsov, et al.
Published: (2015-09-01)

Use of cellular biotechnologies in treatment metastatic pericarditis at patients with tumors of female reproductive system
by: K. S. Titov, et al.
Published: (2014-07-01)

Micrometastases identification in malignant tumors
by: S. A. Kuznetsov, et al.
Published: (2016-03-01)

Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer
by: Ping Yu, et al.
Published: (2023-10-01)

Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer
by: Jessica A. Minott, et al.
Published: (2023-12-01)

ANTICANCER DNA VACCINATION: PRINCIPLE AND PERSPECTIVES OF THE METHOD
by: M. V. Stegantseva, et al.
Published: (2017-05-01)

Clinical and diagnostic value of the functional and conformational properties of serum albumin in patients with ovarian cancer (а pilot study)
by: T. V. Davydova, et al.
Published: (2014-07-01)

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
by: Man Wang, et al.
Published: (2025-01-01)

Resveratrol Targets a Variety of Oncogenic and Oncosuppressive Signaling for Ovarian Cancer Prevention and Treatment
by: Xue-Ling Xu, et al.
Published: (2021-10-01)

Immunotherapy in Recurrent Ovarian Cancer
by: Keyao Chen, et al.
Published: (2025-01-01)

Nanocatalysts for modulating antitumor immunity: fabrication, mechanisms and applications
by: Wu, Xianbo, et al.
Published: (2024)

The Immune Subtypes and Landscape of Advanced-Stage Ovarian Cancer
by: Minjie Zhang, et al.
Published: (2022-09-01)

Serous borderline ovarian tumors (clinical features, morphology, treatment)
by: I. Yu. Davydova, et al.
Published: (2014-07-01)

CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment
by: Ying Zhu, et al.
Published: (2020-04-01)

Immunological aspects of ovarian malignancy
by: Agrimaldo Martins-Filho, et al.
Published: (2022-02-01)

Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies
by: Donald Bastin, et al.
Published: (2016-08-01)

The emerging role of glycolysis and immune evasion in ovarian cancer
by: Bowen Jin, et al.
Published: (2025-03-01)

Borderline ovarian tumors: the issues of chemotherapy and prognosis
by: I. Yu. Davydova, et al.
Published: (2015-09-01)

Interferon-γ and tumor growth
by: A. L. Ilyushin, et al.
Published: (2023-09-01)

Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer
by: Jinye Ding, et al.
Published: (2023-02-01)

Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer
by: Lingling Gao, et al.
Published: (2023-01-01)

Preparation of triangular silver nanoparticles and their biological effects in the treatment of ovarian cancer
by: Man Yin, et al.
Published: (2022-11-01)

Leveraging various extracellular matrix levels to assess prognosis and sensitivity to immunotherapy in patients with ovarian cancer
by: Youqun Huang, et al.
Published: (2023-05-01)

Research progress of immune checkpoint inhibitors in ovarian cancer
by: Lingli Zhao, et al.
Published: (2024-12-01)

Epigenetics Regulates Antitumor Immunity in Melanoma
by: Yuhan Chen, et al.
Published: (2022-05-01)

Recent advances in understanding the immune microenvironment in ovarian cancer
by: Jinxin Chen, et al.
Published: (2024-06-01)

Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice
by: Yuanyuan Wang, et al.
Published: (2025-02-01)

Protein ubiquitination in ovarian cancer immunotherapy: The progress and therapeutic strategy
by: Huiling Guo, et al.
Published: (2024-11-01)

Low molecular weight blood plasma proteome – a source of differential diagnostic biomarkers of ovarian cancer
by: V. Ye. Shevchenko, et al.
Published: (2014-11-01)

Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer
by: Fen Xiao, et al.
Published: (2024-08-01)

Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancer
by: Weiwei Gong, et al.
Published: (2024-08-01)

Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer
by: Shuo-Fu Chen, et al.
Published: (2024-09-01)

Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy
by: Ningning He, et al.
Published: (2024-02-01)

Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus
by: Rafael Cardoso Maciel Costa Silva, et al.
Published: (2023-01-01)

State of Pituitary-Ovarian Link of the Neuroendocrine Regulation System in Women of Reproductive Age with Ovarian Hyperandrogenism
by: Marina A. Darenskaya, et al.
Published: (2024-03-01)

Antitumor Activity of Dehydroxymethylepoxychinomycin (DHMEQ) and Cisplatin Combination in a Model of Disseminated Ovarian Cancer
by: Sh. R. Kzyrgalin, et al.
Published: (2023-10-01)

Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
by: Yuqi Yang, et al.
Published: (2022-10-01)

IMMUNOHISTROCHEMISTRY AND FLOW CYTOMETRIC CHARACTERISTICS OF INTRATUMORAL LYMPHOCYTES IN OVARIAN SEROUS ADENOCARCINOMA
by: E. V. Zuyeva, et al.
Published: (2014-09-01)

Exploration of the Immunotyping Landscape and Immune Infiltration-Related Prognostic Markers in Ovarian Cancer Patients
by: Na Zhao, et al.
Published: (2022-07-01)